Atlas Trials

Xiaorong Dong

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Xiaorong Dong

RecordFirmDate
First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC (NCT05745350)Xiaorong Dong2024-03-07
Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Outcomes in NSCLC Patients With Brain Metastasis (NCT05737589)Xiaorong Dong2023-02-13
Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment (NCT05738317)Xiaorong Dong2022-12-01
Anlotinib In Combination With PD-1/L1 Inhibitor As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study (NCT04313660)Xiaorong Dong2020-04-01
Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy (NCT04333004)Xiaorong Dong2020-04-01
SRS Sequential Sindilimab in Brain Metastasis of NSLSC (NCT04180501)Xiaorong Dong2019-11-01
The Role of Microbiota on the Development of Lung Cancer (NCT03454685)Xiaorong Dong2018-01-30

Track Xiaorong Dong automatically

Every clearance here is in the API, with alerts when new ones post.